Key result
Hindquarters vasoconstriction induced by ouabain was significantly greater in prehypertensive and hypertensive DOCA-salt rats compared to controls (p<0.01).
p-value: p=<0.01
The plasma of DOCA-salt rats contains an inhibitor of the sarcolemmal Na+-K+ pump, but the pump molecules in resistance arteries are increased, suggesting a complex regulation in this hypertension model.
Supports complex Na+-K+ pump regulation in experimental hypertension; leaves open relevance to human disease.
It has been suggested that a circulating inhibitor of the Na(+)-K+ pump contributes to the development and maintenance of DOCA-salt hypertension. However, the discordant results have been reported as to whether the sarcolemmal Na(+)-K+ pump in DOCA-salt hypertension is inhibited. Furthermore, no study has examined alteration in the sarcolemmal Na(+)-K+ pump of the true resistance arteries. We examined hindquarters vasoconstriction induced by ouabain (10(-3) M) in the vascularly isolated hindquarters of the DOCA-salt treated or control rats, which were perfused with Krebs-Henseleit solution. Hindquarters vasoconstriction induced by ouabain (10(-3) M) was greater in the prehypertensive and hypertensive DOCA-salt rats than in the corresponding control rats (p less than 0.01). We also examined hindquarters vasoconstriction induced by ouabain (10(-3) M) in the vascularly isolated hindquarters of the normal assay rats which were perfused by the plasma obtained from the DOCA-salt or control rats. The plasma of the prehypertensive and hypertensive DOCA-salt rats attenuated ouabain-induced hindquarters vasoconstriction in the assay rats (p less than 0.01). The plasma of the DOCA-salt rats did not alter nonspecific vasoconstriction caused by barium chloride. These results suggest that the plasma of the prehypertensive and hypertensive DOCA-salt rats had an inhibitor of the sarcolemmal Na(+)-K+ pump of the resistance arteries, but the sarcolemmal Na(+)-K+ pump molecules of the resistance arteries of those rats were increased. The in vivo activity of the sarcolemmal pump of the resistance arteries of the DOCA-salt rats would be determined by the relative influence of increased pump molecules and a circulating pump inhibitor.
No takes yet. Share an insight, caveat, or question.
Yamamoto et al. (1990) studied DOCA-salt hypertension. DOCA-salt treatment vs. Control rats was evaluated on Hindquarters vasoconstriction induced by ouabain (p=<0.01). Hindquarters vasoconstriction induced by ouabain was significantly greater in prehypertensive and hypertensive DOCA-salt rats compared to controls (p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: